BioSig Commences Clinical Trial Enrollment for PURE EP System
21 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
21 nov. 2019 07h05 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that Japan’s Ministry of Health, Labour...
Federal study finds rampant bias in medical “futile care” decisions
20 nov. 2019 12h31 HE
|
National Council on Disability
WASHINGTON, Nov. 20, 2019 (GLOBE NEWSWIRE) -- WASHINGTON – Today, the National Council on Disability (NCD)—an independent federal agency that advises the President and Congress-- released a study...
S. Parikh Mars, Progressive Care CEO, Answers Shareholder Questions in Exclusive New Interview at SmallCapVoice.com
20 nov. 2019 08h00 HE
|
SmallCapVoice.com; Progressive Care Inc.
MIAMI, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has recently answer...
The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis
20 nov. 2019 07h05 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced that the American College of...
Pillar Marketing Group, Inc., Announces Acquisition Purchase of Controlling interest in Select-TV Solutions, Inc., Changing their name to BioQuest Corp. and Appoints Thomas Hemingway as Chairman and CEO.
18 nov. 2019 08h15 HE
|
BioQuest Corp
Newport Beach, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioQuest Corp, (BQST or the “COMPANY”) (OTC:BQST), (the temporary symbol on 11/15/2019 is SELTD. Please note that a “D” has been appended as the...
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
18 nov. 2019 08h00 HE
|
H-CYTE, Inc.
TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
18 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BIOMEDevice San Jose Announces 2019 Content to Support Digital Health Innovation Enhancing the Patient Experience
14 nov. 2019 11h02 HE
|
BioMEDDevice / ESC San Jose
SANTA MONICA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BIOMEDevice San Jose, Silicon Valley’s leading event for medtech professionals, today announced its 2019 show focus on digital health...
BioSig Technologies Issues November 2019 Shareholder Letter
14 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 14, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...